BenVenue Medical Collects Third Venture Capital Funding
Tuesday, April 19, 2011 5:33:00 AM PDT | VentureDeal Staff
   Santa Clara, California  --  Medical device company BenVenue Medical has secured $35.5 million in its series C round of institutional venture capital investment.

BenVenue is developing minimally invasive surgical solutions to treat spinal disorders.

Domain Associates and Technology Partners led the round, which included previous investors De Novo Ventures and Versant Ventures.

The company said the proceeds would be used to complete its vertebral augmentation treatment system.